A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from Oregon Health & Science University. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.
Listeners of Plenary Session that love the show mention: oncology, vinay, health policy, prasad, evidence based medicine, prassad, oncologists, disparities, always fair, trainees, fda, acronyms, third year, medical students, med student, medical podcast, outcomes, med school, assessment, trials.
The Plenary Session podcast, hosted by Dr. Vinay Prasad, is an intelligent and thought-provoking podcast that delves into a wide range of topics in medicine, with a particular focus on oncology. Dr. Prasad's discussions are filled with valuable information, critical analysis, and a consistent viewpoint that keeps listeners engaged and eager for each new episode. The passion and expertise that Dr. Prasad brings to the table make this podcast a must-listen for anyone interested in staying informed about medical research and healthcare policy.
One of the best aspects of The Plenary Session podcast is Dr. Prasad's data-driven and compassionate perspective. He meticulously examines the scientific evidence behind medical practices and treatments while taking into account the real-world implications for patients. This nuanced approach allows listeners to gain a deeper understanding of complex issues in medicine and challenges them to think critically about established norms and beliefs. Additionally, Dr. Prasad's ability to communicate these ideas in an accessible manner makes this podcast valuable even for those without a medical background.
While there aren't many negative aspects to highlight about The Plenary Session podcast, some listeners might find that they would prefer less time dedicated to the host speaking and more time given to the guests. However, it is worth noting that Dr. Prasad's insights and perspectives are often what make the discussions so engaging, so it may be a matter of personal preference rather than an inherent flaw in the podcast.
In conclusion, The Plenary Session podcast is an exceptional resource for anyone interested in medicine, healthcare policy, or oncology specifically. Dr. Vinay Prasad consistently delivers informative and nuanced discussions that challenge conventional thinking while providing valuable insights into medical research and practice. Whether you're a medical professional or simply someone looking to expand your knowledge on evidence-based medicine, this podcast is sure to leave you informed and inspired.
Back to basics as I break down a trial
I discuss the intense media coverage of Trump and the recent decision to cap indirect costs of NIH grants at 15%.
I discuss RFK Jr.'s confirmation as the US Secretary of Health and Human Services; recent layoffs at the CDC and NIH; and some comments by Harold Varmus in criticism of Jay Bhattacharya.
I discuss the recent reduction in indirect funds for NIH grants and lay out why the NIH is a broken funding system.
I'm talking about USAID and Elon's team of six engineers; the Bobby Kennedy Jr hearings, particularly concerning Samoa; MMR vaccines; DEI; and NIH funding complaints.
I discuss the CIA admitting that COVID was a lab leak; Fauci's pardon; NIH meetings; RFK Jr's Senate confirmation hearing; and more.
I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more!
The entire healthcare system is broken, it's not just health insurance companies.
Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits.
Our 2 hour critical appraisal and ASH review. SO many guest stars
Lecture on systematic review, given by Vinay Prasad MD MPH to students in the UCSF Training in Clinical Research Program, November 2024.
Timothee Olivier and I discuss the top ESMO 2024 abstracts!
AI in healthcare - my latest keynote address
"Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics program.
Screening/ Drug efficacy/ Sotorasib/ Adaura and more
My UCSF lecture on driver mutation lung cancer
We break down the best studies from ASCO
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary Session
What you need to know in advance of ASCO
Should trials have carbon footprint as an endpoint?
My grand rounds; Beta blockers post MI Single center vs multicenter RCT Masks Boosters and more
I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the year
Patient advocates, Pharma funding, and is MRD a suitable endpoint
Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".
They are shitty
Another flawed study Keynote 564. Pembro in adjuvant RCC
What happens when doctors run unethical studies?
Does car T cause secondary AML? We discuss
We talk about 2023 cancer trials
Goodman and I discuss ash updates. My myeloma talk https://www.youtube.com/watch?v=jAz84yCnfjQ
Subscribe to Sensible Med Pod; This is x over Post partum depression, orbita 2 and physics vs medicine
My Lecture in Curacao 4/4 Vaccines, Masks, Mandates, Lockdowns, School closure Other lectures to come
Entresto, Lung Transplants, How to Keep Up with Literature - Lecture to Trainees in Curacao
This is a lecture I gave on November 5, 2023, to pre-medicine undergraduate students at University of California Berkeley.
Radiation oncology in GI malignancy (endpoints and stratification) in the JCO
Prasad is back in Hawaii to give another keynote (good thing they cancelled Dallas not Honolulu). I discuss coffee and colon cancer, and censoring, and Lu177 PSMA
This is a lecture I gave on ethics and institutional review boards in Denmark in September 2023. It is the last of the three lectures I gave.
Mandrola, Prasad and Cifu are back to discuss the latest drama
This is a lecture I gave on the state of immunotherapy in oncology at the Immunotherapy Symposium In Denmark in September 2023. It is the second of three lectures I gave.
The first of the three lectures I gave in Denmark in September 2023 was on the medical evidence behind decision-making by health technology assessment groups.
This is the live recording of a talk given on the great and crazy things we do in medicine, from cancer drugs to boosters and more.
Timothee is back to discuss Malignant and Solutions
A far reaching discussion btw Mandrola and Prasad on RCTs, Coumadin, ECMO and RCTs for covid shots
Simultaneously released on Sensible Medicine. Time to subscribe to Sensible Medicine substack and podcast.
Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover
A sensible medicine crossover episode Follow the sensible medicine podcast feed for more of these discussions
T. Olivier from Geneva is back. A fan favorite guest. We discuss 3 recent papers.
Researchers were too busy counting dead bodies to give the control arm appropriate therapy when their cancer recurred. Disgusting conduct. I break down ADAURA
Mike Putman, Todd C. Lee, John Mandrola and I debate the recent JAMA paper on RCT Duplicate. This is a spirited round table discussion on the limitations of observational data. If you are reading this, leave a comment as a review!
Early treatment of myeloma, dual vs. single maintenance, and finally transplant or no transplant.
© 2020-2025 Ivy Podcast Discovery LLC
